{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T17:58:47Z","timestamp":1780855127635,"version":"3.54.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK127171"],"award-info":[{"award-number":["R01-DK127171"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Microscopic colitis (MC) is a colonic inflammatory bowel disease diagnosed via histology. There are no universally accepted guidelines defining treatment goals in MC. Our study evaluated the prognostic significance of histologic normalization in MC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This retrospective cohort study identified patients with histologically confirmed MC who had at least one repeat colonoscopy with available histology. Outcomes included medical therapy use (anti-diarrheals, steroids, mesalamine, and immunosuppressants), hospitalizations, and surgeries (1) prior to or during first repeat colonoscopy or (2) after first repeat colonoscopy. Multivariable adjusted models were created for medical therapy use after first repeat colonoscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 380 MC patients. On first repeat colonoscopy, 164 (43.2%) patients normalized by histology and were more likely than those with persistent MC changes to have lymphocytic colitis (56.7% vs 43.3%, P\u2009=\u2009.036). There were no differences in hospitalization or surgery rates before or after first repeat colonoscopy for patients who normalized and those who did not. When compared to patients with MC at first repeat colonoscopy, those who normalized had statistically significant lower odds of steroids use after their first repeat colonoscopy (OR 0.26; 0.13-0.53) after multivariate adjustment. This association remained significant when restricted to patients with symptoms at first repeat colonoscopy (OR 0.22; 0.08-0.59) but was weaker for patients without symptoms (OR 0.45; 0.16-1.29).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with MC, histologic normalization at first repeat colonoscopy was associated with reduced need for corticosteroids on follow-up. The effect was slightly attenuated in asymptomatic patients. Future studies of histologic normalization as a treatment target in MC are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izag113","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:43:12Z","timestamp":1779968592000},"source":"Crossref","is-referenced-by-count":0,"title":["The impact of normalization of histology on disease course in microscopic colitis: a retrospective cohort study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-1783","authenticated-orcid":false,"given":"Jennifer Frances Namuli","family":"Kizza-Brown","sequence":"first","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-1821","authenticated-orcid":false,"given":"Ashwin N","family":"Ananthakrishnan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital , Boston, MA,","place":["United States"]},{"name":"Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"2026060713142152800_izag113-B1","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.mayocp.2021.03.022","article-title":"Microscopic colitis: a concise review for clinicians","volume":"96","author":"Tome","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2026060713142152800_izag113-B2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/flgastro-2018-101040","article-title":"Microscopic colitis: diagnosis and management","volume":"10","author":"Townsend","year":"2019","journal-title":"Frontline Gastroenterol"},{"key":"2026060713142152800_izag113-B3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cgh.2024.08.026","article-title":"Update on the epidemiology and management of microscopic colitis","volume":"23","author":"Peery","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060713142152800_izag113-B4","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cgh.2021.06.027","article-title":"The epidemiology of microscopic colitis in olmsted county, Minnesota: population-based study from 2011 to 2019","volume":"20","author":"Tome","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060713142152800_izag113-B5","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/apt.15246","article-title":"A nationwide cohort study of the incidence of microscopic colitis in Sweden","volume":"49","author":"Bergman","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060713142152800_izag113-B6","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/ecco-jcc\/jjaa108","article-title":"Incidence and prevalence of microscopic colitis between 2001 and 2016: a Danish nationwide cohort study","volume":"14","author":"Weimers","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026060713142152800_izag113-B7","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1097\/MIB.0000000000000520","article-title":"Ethnic distribution of microscopic colitis in the United States","volume":"21","author":"Turner","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2026060713142152800_izag113-B8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S2468-1253(19)30048-2","article-title":"Microscopic colitis: pathophysiology and clinical management","volume":"4","author":"Miehlke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026060713142152800_izag113-B9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40266-023-01094-6","article-title":"Diagnosis and pharmacological management of microscopic colitis in geriatric care","volume":"41","author":"Nielsen","year":"2024","journal-title":"Drugs Aging"},{"key":"2026060713142152800_izag113-B10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev-med-050124-092157","article-title":"Microscopic colitis: evidence-based guide to diagnosis and management","volume":"77","author":"Ghoneim","year":"2026","journal-title":"Annu Rev Med"},{"key":"2026060713142152800_izag113-B11","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1111\/jgh.70007","article-title":"Risk factors for microscopic colitis: a systematic review and meta-analysis","volume":"40","author":"Rancz","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"2026060713142152800_izag113-B12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ibd\/izaf215","article-title":"Heterogeneity in histological evaluation of microscopic colitis in randomized clinical trials: an umbrella review","volume":"32","author":"Yuan","year":"2026","journal-title":"Inflamm Bowel Dis"},{"key":"2026060713142152800_izag113-B13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s40265-023-01914-4","article-title":"Effectiveness of non-budesonide therapies in management of microscopic colitis: a systematic review and meta-analysis","volume":"83","author":"Rehde","year":"2023","journal-title":"Drugs"},{"key":"2026060713142152800_izag113-B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2050640620951905","article-title":"European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations","volume":"9","author":"Miehlke","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"2026060713142152800_izag113-B15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1053\/j.gastro.2015.11.008","article-title":"American Gastroenterological Association Institute Guideline on the medical management of microscopic colitis","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"2026060713142152800_izag113-B16","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/ibd\/izad178","article-title":"Effectiveness and safety profile of budesonide maintenance in microscopic colitis: a systematic review and meta-analysis","volume":"30","author":"Tome","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026060713142152800_izag113-B17","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/ibd.20977","article-title":"Defining clinical criteria for clinical remission and disease activity in collagenous colitis","volume":"15","author":"Hjortswang","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2026060713142152800_izag113-B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/1751-2980.12937","article-title":"Histological scores in inflammatory bowel disease","volume":"22","author":"Neri","year":"2021","journal-title":"J Dig Dis"},{"key":"2026060713142152800_izag113-B19","doi-asserted-by":"publisher","first-page":"jjaf040","DOI":"10.1093\/ecco-jcc\/jjaf040","article-title":"Novel outcomes in inflammatory bowel disease","volume":"19","author":"Jairath","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2026060713142152800_izag113-B20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026060713142152800_izag113-B21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41588-022-01156-2","article-title":"Large-scale sequencing identifies multiple genes and rare variants associated with Crohn\u2019s disease susceptibility","volume":"54","author":"Sazonovs","year":"2022","journal-title":"Nat Genet"},{"key":"2026060713142152800_izag113-B22","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1053\/j.gastro.2018.08.042","article-title":"Efficacy and safety of budesonide, vs mesalazine or placebo, as induction therapy for lymphocytic colitis","volume":"155","author":"Miehlke","year":"2018","journal-title":"Gastroenterology"},{"key":"2026060713142152800_izag113-B23","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1053\/j.gastro.2009.02.078","article-title":"Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study","volume":"136","author":"Miehlke","year":"2009","journal-title":"Gastroenterology"},{"key":"2026060713142152800_izag113-B24","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1053\/j.gastro.2014.01.019","article-title":"Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis","volume":"146","author":"Miehlke","year":"2014","journal-title":"Gastroenterology"},{"key":"2026060713142152800_izag113-B25","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1365-2036.2005.02688.x","article-title":"Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide","volume":"22","author":"Miehlke","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060713142152800_izag113-B26","doi-asserted-by":"publisher","first-page":"CD003575","DOI":"10.1002\/14651858.CD003575.pub6","article-title":"Interventions for treating collagenous colitis","volume":"11","author":"Kafil","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026060713142152800_izag113-B27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.14309\/ajg.0000000000002013","article-title":"Histologic activity in an endoscopically normal-appearing pouch predicts future risk of pouchitis in patients with ulcerative colitis","volume":"118","author":"Gupta","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"2026060713142152800_izag113-B28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/apt.13454","article-title":"Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis","volume":"43","author":"Gupta","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2026060713142152800_izag113-B29","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izz313","article-title":"Incidence and predictors of flares in the postpartum year among women with inflammatory bowel disease","volume":"26","author":"Yu","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2026060713142152800_izag113-B30","doi-asserted-by":"publisher","first-page":"e1353","DOI":"10.1016\/j.cgh.2021.08.019","article-title":"Yield and predictors of surveillance colonoscopies in older adults with long-standing ulcerative colitis","volume":"20","author":"Sasson","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026060713142152800_izag113-B31","doi-asserted-by":"publisher","first-page":"2365989","DOI":"10.1080\/07853890.2024.2365989","article-title":"Factors associated with long-term clinical outcome in microscopic colitis","volume":"56","author":"Miyatani","year":"2024","journal-title":"Ann Med"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izag113\/68484863\/izag113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izag113\/68484863\/izag113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T17:14:29Z","timestamp":1780852469000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article\/doi\/10.1093\/ibd\/izag113\/8703424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag113","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"article-number":"izag113"}}